Simba Gill
Direktor/Vorstandsmitglied bei FOGHORN THERAPEUTICS INC.
Vermögen: 199 481 $ am 30.04.2024
Profil
Balkrishan Gill was the founder of moksha8 Pharmaceuticals, Inc. (founded in 2006) where he held the title of President, Chief Executive Officer & Director from 2006 to 2015.
He is currently the Executive Chairman at Serina Therapeutics, Inc. (since 2024) and an Independent Director at Foghorn Therapeutics, Inc. (since 2017).
Previously, he served as the President, Chief Executive Officer & Director at Evelo Biosciences, Inc. (2015-2023), Chairman at Blackfynn, Inc., Director at Codexis, Inc., Director at Realm Therapeutics Plc (2016-2019), and Marketing Director at Roche Diagnostics GmbH.
He also held the position of President & Chief Financial Officer at Maxygen, Inc. (1997-2013) and was a Venture Partner at TPG Growth LLC.
Additionally, he worked as a Scientist at Celltech Ltd.
Dr. Gill holds an MBA from INSEAD and a doctorate from King's College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.04.2024 | 34 061 ( 0,06% ) | 198 576 $ | 31.05.2024 | |
EVELO BIOSCIENCES, INC.
0,10% | 27.11.2023 | 19 688 ( 0,10% ) | 906 $ | 30.04.2024 |
Aktive Positionen von Simba Gill
| Unternehmen | Position | Beginn |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.07.2017 |
Ehemalige bekannte Positionen von Simba Gill
| Unternehmen | Position | Ende |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Vorstandsvorsitzender | 20.11.2023 |
| REALM THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.01.2019 |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Gründer | 01.01.2015 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Finanzdirektor/CFO | 27.11.2013 |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Private Equity Investor | 30.11.2007 |
Ausbildung von Simba Gill
| INSEAD | Masters Business Admin |
| King's College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Blackfynn, Inc.
 Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Technology Services |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
